13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q1 2024. See the latest, Q2 2026 →
Reported value
$1.49T
+14% on the quarter before
Positions
5,353
484 new · 557 sold out
Top 10
32.7%
of the value
Est. gain
+$166.11B
on stocks held all quarter
Est. return
+13.5%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$2.03BAdded · 0.4% → 0.5%+1,528,279 shares
- Walt Disney Company (The)~$1.85BAdded · 0.1% → 0.3%+15,138,817 shares
- Coinbase~$1.70BAdded · 0.1% → 0.2%+6,427,214 shares
- Amazon~$1.61BAdded · 3.7% → 3.9%+8,910,060 shares
- Asml Holding N V~$1.59BAdded · 0.2% → 0.4%+1,634,215 shares
- Meta~$1.49BAdded · 3.6% → 4.5%+3,059,801 shares
- Micron~$1.41BAdded · 0.2% → 0.3%+11,979,545 shares
- Merck & Co Inc~$1.24BAdded · 0.4% → 0.5%+9,370,902 shares
- Astera Labs~$1.22BNew · 0.0% → 0.1%+16,403,971 shares
- Citigroup Inc~$989.3MAdded · 0.0% → 0.1%+15,643,971 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$11.22BCut · 4.9% → 7.0%−12,417,252 shares
- Unitedhealth Group Inc~$3.00BCut · 1.7% → 1.2%−6,061,351 shares
- Hess Corp~$2.73BCut · 0.3% → 0.1%−17,883,283 shares
- Apple~$1.87BCut · 4.4% → 3.3%−10,891,934 shares
- Alphabet~$1.31BCut · 1.3% → 1.1%−8,572,243 shares
- Vertiv~$1.12BCut · 0.2% → 0.2%−13,737,183 shares
- Tesla~$1.11BCut · 0.6% → 0.3%−6,327,166 shares
- Adobe~$1.01BCut · 0.5% → 0.3%−2,002,537 shares
- Vertex Pharmaceuticals Inc~$963.9MCut · 0.4% → 0.3%−2,305,991 shares
- Karuna Therapeutics Inc~$907.1MSold out · 0.1% → 0.0%−2,865,994 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares −9.7% · price +82.5% | 7.0% | $104.00B | +$47.00B | ||||||||
| MicrosoftCOM · shares +0.9% · price +11.9% | 6.2% | $92.92B | +$9.78B | ||||||||
| MetaCL A · shares +2.3% · price +37.2% | 4.5% | $66.40B | +$17.60B | ||||||||
| AmazonCOM · shares +2.8% · price +18.7% | 3.9% | $58.63B | +$8.99B | ||||||||
| AppleCOM · shares −3.6% · price −10.9% | 3.3% | $49.55B | −$6.08B | ||||||||
| AlphabetCAP STK CL A · shares −0.3% · price +8.0% | 2.3% | $34.16B | +$2.54B | ||||||||
| Eli LillyCOM · shares +3.8% · price +33.5% | 1.8% | $26.51B | +$6.41B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares 0% · price +16.9% | 1.4% | $21.21B | +$3.07B | ||||||||
| Unitedhealth Group IncCOM · shares −15% · price −6.0% | 1.2% | $17.65B | −$1.13B | ||||||||
| Exxon Mobil CorpCOM · shares −3.0% · price +16.3% | 1.1% | $16.58B | +$2.32B | ||||||||
| AlphabetCAP STK CL C · shares −7.3% · price +8.0% | 1.1% | $16.53B | +$1.23B | ||||||||
| Visa Inc.COM CL A · shares +2.8% · price +7.2% | 0.99% | $14.81B | +$967.0M | ||||||||
| NetflixCOM · shares −4.3% · price +24.7% | 0.86% | $12.76B | +$2.53B | ||||||||
| General Electric CoCOM NEW · shares +3.7% · price +37.5% | 0.81% | $12.12B | +$3.19B | ||||||||
| SalesforceCOM · shares +1.8% · price +14.5% | 0.75% | $11.11B | +$1.38B | ||||||||
| Jpmorgan Chase & CoCOM · shares +5.2% · price +17.8% | 0.74% | $11.09B | +$1.59B | ||||||||
| Wells Fargo Co NewCOM · shares +5.4% · price +17.8% | 0.73% | $10.83B | +$1.55B | ||||||||
| Regeneron PharmaceuticalsCOM · shares +4.6% · price +9.6% | 0.70% | $10.39B | +$868.7M | ||||||||
| MastercardCL A · shares +1.3% · price +12.9% | 0.67% | $10.04B | +$1.13B | ||||||||
| Boston Scientific CorpCOM · shares +2.7% · price +18.5% | 0.65% | $9.72B | +$1.48B | ||||||||
| UberCOM · shares +2.4% · price +25.0% | 0.65% | $9.66B | +$1.89B | ||||||||
| Marvell Technology IncCOM · shares +0.2% · price +17.5% | 0.62% | $9.21B | +$1.37B | ||||||||
| BroadcomCOM · shares +35% · price +18.7% | 0.52% | $7.77B | +$905.8M | ||||||||
| Bank America CorpCOM · shares +2.3% · price +12.6% | 0.49% | $7.28B | +$796.8M | ||||||||
| Eaton Corp PlcSHS · shares +14% · price +29.8% | 0.48% | $7.22B | +$1.45B | ||||||||
| Total · 5,353 positions | 100% | $1.49T | +$166.11B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 4,725 stocks held throughout, up $166.11B (+13.5%).
- Nvidia+$47.00B+82%
- Meta+$17.60B+37%
- Microsoft+$9.78B+12%
- Amazon+$8.99B+19%
- Eli Lilly+$6.41B+33%
- Unitedhealth Group Inc−$1.13B−6%
- Boeing Co−$1.39B−26%
- Tesla−$1.67B−29%
- Lululemon Athletica Inc−$2.19B−24%
- Apple−$6.08B−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 20 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |